AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca net appreciation / (depreciation) in fair value of investments ($) ($)
Form 11-K Statements of Changes in Net Assets
Latest, FY2025
1,243,285,640
Period ended Dec 31, 2025
Change on a year earlier
+13.9%
1,091,651,164 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net appreciation / (depreciation) in fair value of investments ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,243,285,640 | +13.9% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 1,091,651,164 | +7.2% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 1,017,966,723 | -197.2% | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | -1,047,367,607 | -206.9% | Form 11-K FY2022 (AstraZeneca US 401(k) Plan) ↗ |
| FY2021 | Dec 31, 2021 | 980,087,580 | – | Form 11-K FY2021 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca Net appreciation / (depreciation) in fair value of investments ($) ($), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_net_apprec
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.